Abstract:OBJECTIVE:To investigate the effect of small interfering RNA (siRNA) targeting human vascular endothelial growth factor (hVEGF) on A549 cell growth in nude mice and angiogenesis on chorioallantoic membrane (CAM) assay.METHODS:Three pairs of hVEGF siRNA-plasmid and non-silencing-plasmid were constructed, and transfected into A549 cells through lipofectamine 2000, respectively. The most effective pair of hVEGF siRNA-plasmid was selected by ELISA and real-time RT-PCR. A549 cells transfected with selected hVEGF siRNA- plasmid, A549 cells transfected with non-silencing-plasmid and A549 cells without transfection were inoculated into nude mice, respectively. Chick embryos were randomly divided into four groups and CAM was treated by different solutions for 48 h: culture media DMEM as negative control group,un-transfected A549 cell culture supernatants as positive control group, hVEGF siRNA A549 cell culture supernatants as hVEGF siRNA group and nonsilencing siRNA A549 cell culture supernatants as non-silencing siRNA group. The CAMs were harvested on d12 for microscopic assays.RESULT:Compared with control group, hVEGF siRNA-plasmid induced 48% reduction in hVEGF secretion by A549 cells accompanied by 70% reduction in hVEGF mRNA. Compared with non-silencing siRNA group, the mean tumor volume of murine xenograft was reduced by 58% in hVEGF siRNA group; time for xenografts growing to 50 mm(3)was delayed by 5.4 d. hVEGF contents in xenograft were reduced by 54%; but mean doubling time of tumors and the growth rate of tumors were not significantly reduced. In CAM assays, hVEGF content was zero in negative group, and in hVEGF siRNA group that was 40%-44% of non-silencing siRNA group or positive group; vessels branch points of CAM in hVEGF siRNA group or non-silencing siRNA group or positive group were increased by 45%-55% compared with negative group; total vessel length of CAM in hVEGF siRNA group was increased by 53% compared with negative group, while in non-silencing siRNA group or positive group that was increased by 97% or 99%. Compared with negative control group, the proliferation of microvessels was increased when cell culture supernatant with hVEGF was added in hVEGF siRNA group, significant proliferated vessels were observed in non-silencing siRNA group or positive group.CONCLUSION:A plasmid-mediated hVEGF siRNA has been constructed and verified, which can effectively downregulate the expression of hVEGF in human A549 cells, resulting in the inhibition of angiogenesis. hVEGF siRNA can delay initial growth of A549 tumor xenograft but not reduce the growth rate.

Effects of Human Growth Arrest-Specific Homeobox Gene Delivery on Proliferation, Migration and Cell Cycle Distribution of Vascular Smooth Muscle Cells

[Expression of Human VEGF165 Gene in Rat Bone Marrow Stromal Cells in Vitro].

[Effects on Proliferation and Apoptosis of Serum-Induced Rabbit VSMCs by Adenovirus-Mediated Transfer of the Gax Gene].

[Effect of VEGF Gene Transfer on the Bleomycin-Induced Pulmonary Hypertension in Immature Rabbits].

Gene therapy with human vascular endothelial growth factor in prevention of restenosis after angioplasty

Inhibition of Vascular Smooth Muscle Cell Proliferation by Introduction of Retinoblastoma Gene Via A Recombinant Adenovirus Vector

Hvegf Sirna Inhibits Initial Growth of A549 Tumor Cells in Nude Mice and Angiogenesis on CAM Assay

Early Growth Response Gene-1 Decoy Oligonucleotides Inhibit Vascular Smooth Muscle Cell Proliferation and Neointimal Hyperplasia of Autogenous Vein Graft in Rabbits.

[Adenovirus-Mediated Gene Transfer of Rhsg-1 Inhibits Proliferation of Vascular Smooth Muscle Cells from Spontaneously Hypertensive Rats].

Adenovirus-mediated Hypertension-Related Gene Transfer to Rabbit Carotid Ateries Inhibits Neointimal Formation after Balloon Angioplasty

[The in Vivo and in Vitro Effects on Neovascularization of VEGF Gene Transfer with a New Pseudotyped Raav1 Vector].

Raav-Mediated VEGF Gene Transfer Induces Neovascular Formation in a Rabbit Myocardial Ischemic Model

THE EFFECTS OF THE MYO-ENDOTHELIAL JUNCTION ON THE PHENOTYPIC CHANGES OF VASCULAR SMOOTH MUSCLE CELLS IN EARLY STAGE OF VENOUS AUTOGRAFT IN RATS

Efficient transduction of vascular smooth muscle cells with a translational AAV2.5 vector: a new perspective for in-stent restenosis gene therapy

[Study on Biological Activity of Recombinant Adeno-Associated Virus Vector Co-Expressing Human Vascular Endothelial Growth Factor 165 and Human Bone Morphogenetic Protein 7 Genes in Vitro].

Empirical Study of Transfecting Early Growth Response Gene‐1 DNA Enzyme to Prevent Intimal Hyperlasia of Autogenous Vein Graft in Rats

Effects of Haemopoietic Stem Cell Mobilization on Improving Vein Graft Patency

Transfection of VEGF Gene in Rabbit Mesenchymal Stem Cells and Its Expression

Polymer-based Delivering of Shrna to Rabbit Aortic Smooth Muscle Cells Suppressed the Expression of IGF-1R in Vitro and in Vivo.

Gene Transfer of Human Endothelial Nitric Oxide Synthase Inhibits Proliferation of Human Vascular Smooth Muscle Cells and the Mechanism

Transplantation Of Novel Vascular Endothelial Growth Factor Gene Delivery System Manipulated Skeletal Myoblasts Promote Myocardial Repair